Viacoram 3,5+2,5 mg tabletter Dinamarca - danès - Lægemiddelstyrelsen (Danish Medicines Agency)

viacoram 3,5+2,5 mg tabletter

les laboratoires servier - amlodipin, perindoprilarginin - tabletter - 3,5+2,5 mg

Valdoxan Unió Europea - danès - EMA (European Medicines Agency)

valdoxan

les laboratoires servier - agomelatin - depressiv lidelse, major

Thymanax Unió Europea - danès - EMA (European Medicines Agency)

thymanax

les laboratoires servier - agomelatin - depressiv lidelse, major

Libroxar 2+0,5 mg resoribletter, sublinguale Dinamarca - danès - Lægemiddelstyrelsen (Danish Medicines Agency)

libroxar 2+0,5 mg resoribletter, sublinguale

laboratoires smb s.a. - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 2+0,5 mg

Libroxar 8+2 mg resoribletter, sublinguale Dinamarca - danès - Lægemiddelstyrelsen (Danish Medicines Agency)

libroxar 8+2 mg resoribletter, sublinguale

laboratoires smb s.a. - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 8+2 mg

Fixopost 50 mikrogram/ml+5 mg/ml øjendråber, opløsning Dinamarca - danès - Lægemiddelstyrelsen (Danish Medicines Agency)

fixopost 50 mikrogram/ml+5 mg/ml øjendråber, opløsning

laboratoires thea s.a.s. - latanoprost, timololmaleat - øjendråber, opløsning - 50 mikrogram/ml+5 mg/ml

Tibsovo Unió Europea - danès - EMA (European Medicines Agency)

tibsovo

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastiske midler - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.

Elymbus 0,1 mg/g øjengel, enkeltdosisbeholder Dinamarca - danès - Lægemiddelstyrelsen (Danish Medicines Agency)

elymbus 0,1 mg/g øjengel, enkeltdosisbeholder

laboratoires thea s.a.s. - bimatoprost - øjengel, enkeltdosisbeholder - 0,1 mg/g

Clopidogrel BGR (previously Zylagren) Unió Europea - danès - EMA (European Medicines Agency)

clopidogrel bgr (previously zylagren)

biogaran - clopidogrel (as hydrogen sulfate) - peripheral vascular diseases; stroke; myocardial infarction - antitrombotiske midler - forebyggelse af atherothrombotic begivenheder clopidogrel er indiceret i:voksne patienter med myokardieinfarkt (fra få dage, indtil der er mindre end 35 dage), iskæmisk slagtilfælde (fra 7 dage indtil mindre end 6 måneder) eller etableret perifer arteriel sygdom.

Savene Unió Europea - danès - EMA (European Medicines Agency)

savene

clinigen healthcare b.v. - dexrazoxanhydrochlorid - ekstravasation af diagnostiske og terapeutiske materialer - alle andre terapeutiske produkter - savene er indiceret til behandling af anthracyclin-ekstravasation.